Phase Ib multiple dose ascending trial of CPP 115 in volunteers.

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 01 Oct 2016

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CPP 115 (Primary)
Indications Infantile spasms
Focus Adverse reactions

Most Recent Events

19 Sep 2016 According to a Catalyst Pharmaceutical media release, case study report of a patient from this study was accepted to be published in the journal of Epilepsy & Behavior Case Reports.
19 Sep 2016 A case study report published in a Catalyst Pharmaceutical media release.
16 Dec 2015 Top-line results published in a Catalyst Pharmaceutical media release.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight